A Better Year for Drug Approvals? Not Really

By FDA's count, novel drug approvals were up more than 30% in 2008, to a respectable 24. Unfortunately, the number of Innovative Commercial Therapies was no better than it has been for the past four years. But it could have been worse.

More from Archive

More from Pink Sheet